Aims This study evaluates 10-year follow-up data on associated comorbidity, mortality, and
pharmacological treatment patterns for men and women with different stages of peripheral …

Background Peripheral arterial disease (PAD) is a marker of advanced atherosclerosis with
an elevated risk of cardiovascular mortality and morbidity. Although intensive risk reduction …

Background Patients with peripheral arterial disease (PAD) are at very high risk for
cardiovascular events. How do patients with PAD differ from age-and sex-matched controls …

Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a
high risk of cardiovascular and limb symptoms and complications, which affects their quality …

The charts of all 561 patients (69% men and 31% women, mean age 71±10 years) with
peripheral arterial disease (PAD) followed in an academic vascular surgery clinic were …

Peripheral arterial diseases comprise different clinical presentations, from cerebrovascular
disease down to lower extremity artery disease, from subclinical to disabling symptoms and …

Objective To determine cardiovascular comorbidities and use of cardiovascular disease
preventive drugs in patients with peripheral arterial disease (PAD), with special attention to …

Background Statin use is recommended in all patients with peripheral arterial disease (PAD)
owing to its morbidity and mortality benefits. However, the effect of statin use on limb salvage …

Background: Patients with peripheral artery disease (PAD) are at risk of major adverse
cardiac and cerebrovascular events. There are no readily available risk scores that can …

BACKGROUND: Previous studies have documented an undertreatment of vascular risk
factors, and patients with symptomatic peripheral arterial disease (PAD) are at increased risk …